Literature DB >> 27531347

Prospective observational cohort study of postoperative risk and prognosis scoring for elderly patients with medically operable lung cancer (JACS1303).

Hisashi Saji1,2, Takahiko Ueno3, Hiroshige Nakamura4.   

Abstract

Entities:  

Year:  2016        PMID： 27531347     DOI： 10.1007/s11748-016-0701-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN： 1863-6705


× No keyword cloud information.
  2 in total

1.  Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.

Authors:  Jiro Okami; Masahiko Higashiyama; Hisao Asamura; Tomoyuki Goya; Yoshihiko Koshiishi; Yasunori Sohara; Kenji Eguchi; Masaki Mori; Yoichi Nakanishi; Ryosuke Tsuchiya; Etsuo Miyaoka
Journal:  J Thorac Oncol       Date:  2009-10       Impact factor: 15.609

2.  Thoracic and cardiovascular surgery in Japan during 2013: Annual report by The Japanese Association for Thoracic Surgery.

Authors:  Munetaka Masuda; Hiroyuki Kuwano; Meinoshin Okumura; Hirokuni Arai; Shunsuke Endo; Yuichiro Doki; Junjiro Kobayashi; Noboru Motomura; Hiroshi Nishida; Yoshikatsu Saiki; Fumihiro Tanaka; Kazuo Tanemoto; Yasushi Toh; Hiroyasu Yokomise
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-12
  2 in total
  2 in total

1.  Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis.

Authors:  Takuro Miyazaki; Takuya Yamazaki; Daisuke Nakamura; Shuntaro Sato; Naoya Yamasaki; Tomoshi Tsuchiya; Keitaro Matsumoto; Ryotaro Kamohara; Go Hatachi; Takeshi Nagayasu
Journal:  Surg Today       Date:  2017-04-26       Impact factor: 2.549

2.  The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303.

Authors:  Takuro Miyazaki; Hisashi Saji; Hiroshige Nakamura; Takeshi Nagayasu; Norihito Okumura; Masanori Tsuchida; Makoto Sonobe; Keiju Aokage; Masayuki Nakao; Tomohiro Haruki; Morihito Okada; Kenji Suzuki; Masayuki Chida; Ichiro Yoshino
Journal:  Surg Today       Date:  2022-02-24       Impact factor: 2.540
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.